Dengue Virus Co-infections with Multiple Serotypes Do Not Result in a Different Clinical Outcome Compared to Mono-infections

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 2020 Jun 30

PMID 32594967

Citations 13

Authors

U T N Senaratne

K Murugananthan

P D N N Sirisena

J M Carr

F Noordeen

Affiliations

Soon will be listed here.

Abstract

Circulation of multiple dengue virus (DENV) serotypes in a locale has resulted in individuals becoming infected with mixed serotypes. This research was undertaken to study the clinical presentation, presence of DENV serotypes and serological characteristics of DENV infected patients with co-infections from three Provinces of Sri Lanka where DENV-1 and -2 predominated during the study. A reverse transcription polymerase chain reaction was performed on 1249 patient samples and 301 were positive for DENV (24.1%). DENV-1 was the predominant serotype detected in 137 (45.51%) followed by DENV-2 in 65 (21.59%), DENV-3 in 59 (19.6%) and DENV-4 in 4 (1.32%) patients with mono-infections. Thirty-three patients (10.96%) had DENV co-infections with two or more serotypes. The highest number of co-infections was noted between DENV-1 and DENV-2 (57.57%) suggesting co-infection is driven by the frequency of the circulating serotypes. Platelet counts were significantly higher in DENV co-infected patients although clinical disease severity or white blood cell count, packed cell volume or viraemia were not significantly different in the co-infected compared to the mono-infected patients. Thus co-infection with multiple DENV serotypes does occur but with the exception of improved platelet counts in co-infected patients, there is no evidence that clinical or laboratory measures of disease are altered.

Citing Articles

Prevalence of dengue and leptospirosis coinfection and associated mortality rates: a systematic review and meta-analysis.

Tiwari S, Khatib M, Mm R, Kaur M, Sharma G, Sudan P BMC Infect Dis. 2025; 25(1):111.

PMID: 39856559 PMC: 11760719. DOI: 10.1186/s12879-025-10498-1.

Dengue Mimickers: Which Clinical Conditions Can Resemble Dengue Fever?.

Farias L, Costa L, Bessa P, Alcantara G, Oliveira J, Silva T Rev Soc Bras Med Trop. 2024; 57:e002062024.

PMID: 39699542 PMC: 11654470. DOI: 10.1590/0037-8682-0334-2024.

Clinical and laboratory comparison of severe (Group B and C) Dengue cases with molecular characterization from 2019 epidemics in Dhaka, Bangladesh.

Chowdhury F, Hossain Z, Parvez N, Chowdhury F, Bari M, Deb S PLoS Negl Trop Dis. 2024; 18(11):e0012686.

PMID: 39585911 PMC: 11627391. DOI: 10.1371/journal.pntd.0012686.

Epidemiological burden of dengue in Sri Lanka: A systematic review of literature from 2000-2020.

Fernando L, Wickramasinghe V, Kalra P, Kastner R, Gallagher E IJID Reg. 2024; 13:100436.

PMID: 39386112 PMC: 11462220. DOI: 10.1016/j.ijregi.2024.100436.

Multiplex Reverse Transcription Polymerase Chain Reaction Combined with a Microwell Hybridization Assay Screening for Arbovirus and Parasitic Infections in Febrile Patients Living in Endemic Regions of Colombia.

Calderon-Ruiz P, Haist G, Mascus A, Holguin-Rocha A, Koliopoulos P, Daniel T Trop Med Infect Dis. 2023; 8(10).

PMID: 37888594 PMC: 10610613. DOI: 10.3390/tropicalmed8100466.

References

Dhanoa A, Hassan S, Ngim C, Lau C, Chan T, Adnan N . Impact of dengue virus (DENV) co-infection on clinical manifestations, disease severity and laboratory parameters. BMC Infect Dis. 2016; 16(1):406. PMC: 4982428. DOI: 10.1186/s12879-016-1731-8. View

Senaratne T, Wimalaratne H, Alahakoon D, Gunawardane N, Carr J, Noordeen F . Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever. J Med Virol. 2016; 88(10):1703-10. DOI: 10.1002/jmv.24525. View

Meiyu F, Huosheng C, Cuihua C, Xiaodong T, Lianhua J, Yifei P . Detection of flaviviruses by reverse transcriptase-polymerase chain reaction with the universal primer set. Microbiol Immunol. 1997; 41(3):209-13. DOI: 10.1111/j.1348-0421.1997.tb01192.x. View

Lorono-Pino M, Cropp C, Farfan J, Vorndam A, Beaty B, Gubler D . Common occurrence of concurrent infections by multiple dengue virus serotypes. Am J Trop Med Hyg. 1999; 61(5):725-30. DOI: 10.4269/ajtmh.1999.61.725. View

Kanakaratne N, Wahala W, Messer W, Tissera H, Shahani A, Abeysinghe N . Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis. 2009; 15(2):192-9. PMC: 2662655. DOI: 10.3201/eid1502.080926. View

Phommanivong V, Kanda S, Shimono T, Lamaningao P, Darcy A, Mishima N . Co-circulation of the dengue with chikungunya virus during the 2013 outbreak in the southern part of Lao PDR. Trop Med Health. 2016; 44:24. PMC: 4973078. DOI: 10.1186/s41182-016-0020-y. View

Rico-Hesse R . Microevolution and virulence of dengue viruses. Adv Virus Res. 2003; 59:315-41. PMC: 3045824. DOI: 10.1016/s0065-3527(03)59009-1. View

Thai K, Henn M, Zody M, Tricou V, Minh Nguyet N, Charlebois P . High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections. J Virol. 2011; 86(2):835-43. PMC: 3255838. DOI: 10.1128/JVI.05985-11. View

Vaughn D, Green S, Kalayanarooj S, Innis B, Nimmannitya S, Suntayakorn S . Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 1999; 181(1):2-9. DOI: 10.1086/315215. View

10.

VinodKumar C, Kalapannavar N, Basavarajappa K, Sanjay D, Gowli C, Nadig N . Episode of coexisting infections with multiple dengue virus serotypes in central Karnataka, India. J Infect Public Health. 2013; 6(4):302-6. DOI: 10.1016/j.jiph.2013.01.004. View

11.

Laille M, Deubel V . Demonstration of concurrent dengue 1 and dengue 3 infection in six patients by the polymerase chain reaction. J Med Virol. 1991; 34(1):51-4. DOI: 10.1002/jmv.1890340109. View

12.

N Sirisena P, Noordeen F . Evolution of dengue in Sri Lanka-changes in the virus, vector, and climate. Int J Infect Dis. 2013; 19:6-12. DOI: 10.1016/j.ijid.2013.10.012. View

13.

Villabona-Arenas C, de Oliveira J, Capra C, Balarini K, Loureiro M, Fonseca C . Detection of four dengue serotypes suggests rise in hyperendemicity in urban centers of Brazil. PLoS Negl Trop Dis. 2014; 8(2):e2620. PMC: 3937275. DOI: 10.1371/journal.pntd.0002620. View

14.

Gubler D, Kuno G, SATHER G, Waterman S . A case of natural concurrent human infection with two dengue viruses. Am J Trop Med Hyg. 1985; 34(1):170-3. DOI: 10.4269/ajtmh.1985.34.170. View

15.

Li D, Lott W, Lowry K, Jones A, Thu H, Aaskov J . Defective interfering viral particles in acute dengue infections. PLoS One. 2011; 6(4):e19447. PMC: 3084866. DOI: 10.1371/journal.pone.0019447. View

16.

Messer W, Gubler D, Harris E, Sivananthan K, de Silva A . Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis. 2003; 9(7):800-9. PMC: 3023445. DOI: 10.3201/eid0907.030038. View

17.

Burivong P, Pattanakitsakul S, Thongrungkiat S, Malasit P, Flegel T . Markedly reduced severity of Dengue virus infection in mosquito cell cultures persistently infected with Aedes albopictus densovirus (AalDNV). Virology. 2004; 329(2):261-9. DOI: 10.1016/j.virol.2004.08.032. View

18.

Maneekarn N, Morita K, Tanaka M, Igarashi A, Usawattanakul W, Sirisanthana V . Applications of polymerase chain reaction for identification of dengue viruses isolated from patient sera. Microbiol Immunol. 1993; 37(1):41-7. DOI: 10.1111/j.1348-0421.1993.tb03177.x. View

19.

Lanciotti R, Calisher C, Gubler D, Chang G, Vorndam A . Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992; 30(3):545-51. PMC: 265106. DOI: 10.1128/jcm.30.3.545-551.1992. View

20.

Chow V, Seah C, Chan Y . Use of NS3 consensus primers for the polymerase chain reaction amplification and sequencing of dengue viruses and other flaviviruses. Arch Virol. 1993; 133(1-2):157-70. DOI: 10.1007/BF01309751. View